| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.065 | 0.2 |